Monovisc

— THERAPEUTIC CATEGORIES —
  • Arthritis/rheumatic disorders

Monovisc Generic Name & Formulations

General Description

Sodium hyaluronate 22mg/mL; viscoelastic soln for intra-articular inj.

Pharmacological Class

Hyaluronan.

How Supplied

Single-use syringe (4mL)—1

Manufacturer

Generic Availability

NO

Monovisc Indications

Indications

Treatment of pain in osteoarthritis of the knee in patients who have failed to respond adequately to conservative nonpharmacologic therapy or simple analgesics (eg, acetaminophen).

Monovisc Dosage and Administration

Adult

Remove synovial fluid or effusion before inj. Give as a single intra-articular inj. 4mL in one knee only. If bilateral treatment: use one syringe in each knee.

Children

≤21yrs: not established.

Monovisc Contraindications

Contraindications

Gram (+) bacterial protein allergy. Infections or skin diseases in area of inj site/joint. Systemic bleeding disorders.

Monovisc Boxed Warnings

Not Applicable

Monovisc Warnings/Precautions

Warnings/Precautions

Avoid strenuous or prolonged weight-bearing activities within 48hrs following inj. Pregnancy, nursing mothers: not established.

Monovisc Pharmacokinetics

See Literature

Monovisc Interactions

Interactions

Avoid use of disinfectants containing quaternary ammonium salts; hyaluronan can precipitate in their presence.

Monovisc Adverse Reactions

Adverse Reactions

Arthralgia, joint swelling, inj site pain.

Monovisc Clinical Trials

See Literature

Monovisc Note

Not Applicable

Monovisc Patient Counseling

See Literature